Professional Documents
Culture Documents
Ebook Small Non Coding Rnas Methods and Protocols Mathieu Rederstorff Editor Online PDF All Chapter
Ebook Small Non Coding Rnas Methods and Protocols Mathieu Rederstorff Editor Online PDF All Chapter
https://ebookmeta.com/product/long-non-coding-rnas-lin-zhang-
xiaowen-hu-ed/
https://ebookmeta.com/product/non-ribosomal-peptide-biosynthesis-
and-engineering-methods-and-protocols-methods-in-molecular-
biology-2670-michael-burkart-editor/
https://ebookmeta.com/product/non-ribosomal-peptide-biosynthesis-
and-engineering-methods-and-protocols-methods-in-molecular-
biology-2670-michael-burkart-editor-fumihiro-ishikawa-editor/
https://ebookmeta.com/product/cancer-biomarkers-methods-and-
protocols-gagan-deep-editor/
Rhodopsin Methods and Protocols Methods in Molecular
Biology 2501 Valentin Gordeliy (Editor)
https://ebookmeta.com/product/rhodopsin-methods-and-protocols-
methods-in-molecular-biology-2501-valentin-gordeliy-editor/
https://ebookmeta.com/product/ferroptosis-methods-and-protocols-
methods-in-molecular-biology-2712-guido-kroemer-editor/
https://ebookmeta.com/product/dnazymes-methods-and-protocols-
methods-in-molecular-biology-2439-gerhard-steger-editor/
https://ebookmeta.com/product/ferroptosis-methods-and-protocols-
methods-in-molecular-biology-2712-guido-kroemer-editor-daolin-
tang-editor/
https://ebookmeta.com/product/monoamine-oxidase-methods-and-
protocols-methods-in-molecular-biology-2558-claudia-binda-editor/
Methods in
Molecular Biology 2300
Small Non-
Coding RNAs
Methods and Protocols
Second Edition
METHODS IN MOLECULAR BIOLOGY
Series Editor
John M. Walker
School of Life and Medical Sciences
University of Hertfordshire
Hatfield, Hertfordshire, UK
Second Edition
Edited by
Mathieu Rederstorff
Université de Lorraine, CNRS, IMoPA, Nancy, France
Editor
Mathieu Rederstorff
Université de Lorraine
CNRS, IMoPA
Nancy, France
This Humana imprint is published by the registered company Springer Science+Business Media, LLC, part of Springer
Nature.
The registered company address is: 1 New York Plaza, New York, NY 10004, U.S.A.
Preface
Small Non-Coding RNAs: Methods and Protocols is a laboratory protocols book dedicated to
biochemists or cellular/molecular biologists, already working in the field of RNA biology or
willing to start studying small non-coding RNAs in their projects.
Owing to their small sizes, tri-dimensional structures, low abundances, or differential
expression levels, small non-coding RNAs require customized dedicated protocols for their
identification and study, compared, for instance, to messenger RNAs (mRNAs).
This volume contains basic as well as more sophisticated, state-of-the-art methods to
tackle all aspects of small non-coding RNA biology, from their isolation and precipitation,
through their quantification, accurate detection, functional analysis, to their high-
throughput or even structural analysis.
This survey of technologies will be of valuable help to all the researchers interested in
studying the numerous functions of small non-coding RNAs.
I sincerely thank all the authors for their contribution to this exciting second edition.
v
Contents
Preface . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . v
Contributors. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . ix
vii
viii Contents
Index . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 267
Contributors
ix
x Contributors
KRISTINA LARTER • Department of Genetics and Stanley S. Scott Cancer Center, Louisiana
State University Health Sciences Center, New Orleans, LA, USA
ISABELLE LEBARS • Université de Strasbourg, CNRS, ARN UPR 9002, 2 allée Conrad
Roentgen, Strasbourg, France
SYLVAIN MAENNER • Université de Lorraine, CNRS, IMoPA, Nancy, France
XAVIER MANIVAL • Université de Lorraine, CNRS, IMoPA, Nancy, France
VIRGINIE MARCHAND • Université de Lorraine, CNRS, INSERM, IBSLOR, Nancy, France
FRANCK MARTIN • Université de Strasbourg—Institut de Biologie Moléculaire et Cellulaire,
“Architecture et Réactivité de l’ARN” CNRS UPR9002, Strasbourg, France
YURI MOTORIN • Université de Lorraine, CNRS, INSERM, IBSLOR, Nancy, France;
Université de Lorraine, CNRS, IMoPA, Nancy, France
MARC QUINTERNET • Université de Lorraine, CNRS, INSERM, IBSLOR, Nancy, France
MATHIEU REDERSTORFF • Université de Lorraine, CNRS, IMoPA, Nancy, France
MICHAEL RYCKELYNCK • Université de Strasbourg, CNRS, Architecture et Réactivité de
l’ARN, UPR 9002, Strasbourg, France
AYMERIC SANCHEZ • Université de Lorraine, CNRS, IMoPA, Nancy, France
M. AMRI C. SCHLÜTER • Institute of Pharmaceutical Chemistry, Philipps-University
Marburg, Marburg, Germany
QUENTIN THUILLIER • Université de Lorraine, CNRS, IMoPA, Nancy, France
ANNE-SOPHIE TILLAULT • Department of Chemistry and Biochemistry, Alberta RNA
Research and Training Institute, University of Lethbridge, Lethbridge, AB, Canada
VALENTIN VAUTROT • Université de Lorraine, CNRS, IMoPA, Nancy, France
MARLÈNE VAYSSIÈRES • Laboratoire CiTCoM “Cibles Thérapeutique et Conception des Mé
dicaments”, CNRS UMR 8038, Faculté de Pharmacie, Université de Paris, Paris, France
CAMILLE VIRCIGLIO • Université de Lorraine, CNRS, IMoPA, Nancy, France
JÖRG VOGEL • Institute of Molecular Infection Biology, University of Würzburg, Würzburg,
Germany; Helmholtz Institute for RNA-based Infection Research (HIRI), Helmholtz
Centre for Infection Research (HZI), Würzburg, Germany
JANA C. WIEGARD • Institute of Pharmaceutical Chemistry, Philipps-University Marburg,
Marburg, Germany
YAGUANG XI • Department of Genetics and Stanley S. Scott Cancer Center, Louisiana State
University Health Sciences Center, New Orleans, LA, USA
BIN YI • Department of Genetics and Stanley S. Scott Cancer Center, Louisiana State
University Health Sciences Center, New Orleans, LA, USA
Part I
Abstract
The discovery of new classes of non-coding RNAs has always been preceded or accompanied by techno-
logical breakthroughs, and these outstanding progresses in transcriptomics approaches enabled to regularly
add new members to the list. From the first detection of tRNAs, through the revolution of miRNAs
discovery, to the recent identification of eRNAs or the identification of new functions for already known
ncRNAs, this introductive review provides a very concise historical and functional overview of most
prominent small regulatory non-coding RNA families.
Key words miRNA, snoRNA, piRNA, tRNA, rRNA, tiRNA, snRN, eRNA, ceRNA, circRNA
It has been more than 60 years that the first soluble cytoplasmic
small non-coding RNA (sncRNA), a yeast alanine transfer RNA
(tRNA), was identified and its primary structure determined
[1, 2]. Together with ribosomal RNAs (rRNA), the nucleic acids
moieties of the ribosomes, tRNAs play a central role in protein
synthesis, as the adaptor molecules providing the correct amino
acid in response to a specific codon on the mRNA [3]. Only
20 years later were the first nuclear RNAs uncovered: uridine-rich
RNAs, or U-RNAs, were observed to be very abundant, nucleus, or
sometimes even nucleolus specific and highly conserved [4, 5];
small nuclear RNAs (snRNA) U1, U2, U4, U5, and U6 were
later shown to be involved in splicing, in association with several
proteins within a ribonucleoprotein particle (RNP) called spliceo-
some [6]. Base pairings among snRNAs and between snRNAs and
pre-messenger RNA (pre-mRNA) regions account for the proper
conformation of both spliceosome and pre-mRNA, eventually lead-
ing to release of the introns and mature mRNAs [7]. Interestingly,
most small nucleolar RNAs (snoRNAs) are processed from the
released introns [8]. Within snoRNPs, snoRNAs guide post-
transcriptional RNA modifications of other ncRNAs, e.g., rRNAs
Mathieu Rederstorff (ed.), Small Non-Coding RNAs: Methods and Protocols, Methods in Molecular Biology, vol. 2300,
https://doi.org/10.1007/978-1-0716-1386-3_1, © Springer Science+Business Media, LLC, part of Springer Nature 2021
3
4 Camille Virciglio et al.
Acknowledgments
References
1. Holley RW, Apgar J, Doctor BP (1960) Sepa- 7. Lerner MR, Boyle JA, Mount SM, Wolin SL,
ration of amino acid-specific “soluble”-fraction Steitz JA (1980) Are snRNPs involved in splic-
ribonucleic acids. Ann N Y Acad Sci ing? Nature 283(5743):220–224
88:745–751 8. Matera AG, Terns RM, Terns MP (2007)
2. Holley RW, Apgar J, Everett GA, Madison JT, Non-coding RNAs: lessons from the small
Marquisee M, Merrill SH, Penswick JR, Zamir nuclear and small nucleolar RNAs. Nat Rev
A (1965) Structure of a ribonucleic acid. Sci- Mol Cell Biol 8(3):209–220. https://doi.
ence 147(3664):1462–1465 org/10.1038/nrm2124
3. Eddy SR (2001) Non-coding RNA genes and 9. Marmier-Gourrier N, Clery A, Schlotter F,
the modern RNA world. Nat Rev Genet 2 Senty-Segault V, Branlant C (2011) A second
(12):919–929. https://doi.org/10.1038/ base pair interaction between U3 small nucleo-
35103511 lar RNA and the 50 -ETS region is required for
4. Busch H, Reddy R, Rothblum L, Choi YC early cleavage of the yeast pre-ribosomal RNA.
(1982) SnRNAs, SnRNPs, and RNA proces- Nucleic Acids Res 39(22):9731–9745.
sing. Annu Rev Biochem 51:617–654. https://doi.org/10.1093/nar/gkr675
https://doi.org/10.1146/annurev.bi.51. 10. Clerget G, Bourguignon-Igel V, Marmier-
070182.003153 Gourrier N, Rolland N, Wacheul L,
5. Weinberg RA, Penman S (1968) Small molec- Manival X, Charron C, Kufel J, Méreau A,
ular weight monodisperse nuclear RNA. J Mol Senty-Ségault V, Tollervey D, Lafontaine
Biol 38(3):289–304. https://doi.org/10. DLJ, Branlant C, Rederstorff M (2020) Syner-
1016/0022-2836(68)90387-2 gistic defects in pre-rRNA processing from
6. Lerner MR, Steitz JA (1979) Antibodies to mutations in the U3-specific protein Rrp9 and
small nuclear RNAs complexed with proteins U3 snoRNA. Nucleic Acids Res
are produced by patients with systemic lupus 48:3848–3868. https://doi.org/10.1093/
erythematosus. Proc Natl Acad Sci U S A 76 nar/gkaa066
(11):5495–5499
ncRNAs Overview 7
11. Abel Y, Rederstorff M (2019) SnoRNAs and 21. Pfeffer S, Zavolan M, Grasser FA, Chien M,
the emerging class of sdRNAs: multifaceted Russo JJ, Ju J, John B, Enright AJ, Marks D,
players in oncogenesis. Biochimie 164:17–21. Sander C, Tuschl T (2004) Identification of
https://doi.org/10.1016/j.biochi.2019.05. virus-encoded microRNAs. Science 304
006 (5671):734–736. https://doi.org/10.1126/
12. Huttenhofer A, Kiefmann M, Meier-Ewert S, science.1096781
O’Brien J, Lehrach H, Bachellerie JP, Brosius J 22. Fire A, Xu S, Montgomery MK, Kostas SA,
(2001) RNomics: an experimental approach Driver SE, Mello CC (1998) Potent and spe-
that identifies 201 candidates for novel, small, cific genetic interference by double-stranded
non-messenger RNAs in mouse. EMBO J 20 RNA in Caenorhabditis elegans. Nature 391
(11):2943–2953. https://doi.org/10.1093/ (6669):806–811. https://doi.org/10.1038/
emboj/20.11.2943 35888
13. Wightman B, Burglin TR, Gatto J, Arasu P, 23. Hutvagner G, McLachlan J, Pasquinelli AE,
Ruvkun G (1991) Negative regulatory Balint E, Tuschl T, Zamore PD (2001) A cellu-
sequences in the lin-14 30 -untranslated region lar function for the RNA-interference enzyme
are necessary to generate a temporal switch dicer in the maturation of the let-7 small tem-
during Caenorhabditis elegans development. poral RNA. Science 293(5531):834–838.
Genes Dev 5(10):1813–1824 https://doi.org/10.1126/science.1062961
14. Lee RC, Feinbaum RL, Ambros V (1993) The 24. Napoli C, Lemieux C, Jorgensen R (1990)
C. elegans heterochronic gene lin-4 encodes Introduction of a chimeric chalcone synthase
small RNAs with antisense complementarity gene into petunia results in reversible
to lin-14. Cell 75(5):843–854. https://doi. co-suppression of homologous genes in trans.
org/10.1016/0092-8674(93)90529-y Plant Cell 2(4):279–289. https://doi.org/10.
15. Wightman B, Ha I, Ruvkun G (1993) Post- 1105/tpc.2.4.279
transcriptional regulation of the heterochronic 25. Bartel DP (2004) MicroRNAs: genomics, bio-
gene lin-14 by lin-4 mediates temporal pattern genesis, mechanism, and function. Cell 116
formation in C. elegans. Cell 75(5):855–862. (2):281–297. https://doi.org/10.1016/
https://doi.org/10.1016/0092-8674(93) s0092-8674(04)00045-5
90530-4 26. Ender C, Krek A, Friedlander MR,
16. Pasquinelli AE, Reinhart BJ, Slack F, Martin- Beitzinger M, Weinmann L, Chen W,
dale MQ, Kuroda MI, Maller B, Hayward DC, Pfeffer S, Rajewsky N, Meister G (2008) A
Ball EE, Degnan B, Muller P, Spring J, human snoRNA with microRNA-like func-
Srinivasan A, Fishman M, Finnerty J, Corbo J, tions. Mol Cell 32(4):519–528. https://doi.
Levine M, Leahy P, Davidson E, Ruvkun G org/10.1016/j.molcel.2008.10.017
(2000) Conservation of the sequence and tem- 27. Rother S, Meister G (2011) Small RNAs
poral expression of let-7 heterochronic regu- derived from longer non-coding RNAs. Bio-
latory RNA. Nature 408(6808):86–89. chimie 93(11):1905–1915. https://doi.org/
https://doi.org/10.1038/35040556 10.1016/j.biochi.2011.07.032
17. Lagos-Quintana M, Rauhut R, Lendeckel W, 28. Tuschl T, Zamore PD, Lehmann R, Bartel DP,
Tuschl T (2001) Identification of novel genes Sharp PA (1999) Targeted mRNA degradation
coding for small expressed RNAs. Science 294 by double-stranded RNA in vitro. Genes Dev
(5543):853–858. https://doi.org/10.1126/ 13(24):3191–3197
science.1064921 29. Zamore PD, Tuschl T, Sharp PA, Bartel DP
18. Lau NC, Lim LP, Weinstein EG, Bartel DP (2000) RNAi: double-stranded RNA directs
(2001) An abundant class of tiny RNAs with the ATP-dependent cleavage of mRNA at
probable regulatory roles in Caenorhabditis 21 to 23 nucleotide intervals. Cell 101
elegans. Science 294(5543):858–862. (1):25–33. https://doi.org/10.1016/S0092-
https://doi.org/10.1126/science.1065062 8674(00)80620-0
19. Lee RC, Ambros V (2001) An extensive class of 30. Braun JE, Huntzinger E, Izaurralde E (2013)
small RNAs in Caenorhabditis elegans. Science The role of GW182 proteins in miRNA-
294(5543):862–864. https://doi.org/10. mediated gene silencing. Adv Exp Med Biol
1126/science.1065329 768:147–163. https://doi.org/10.1007/
20. Nathans R, Chu CY, Serquina AK, Lu CC, 978-1-4614-5107-5_9
Cao H, Rana TM (2009) Cellular microRNA 31. Eulalio A, Tritschler F, Izaurralde E (2009)
and P bodies modulate host-HIV-1 interac- The GW182 protein family in animal cells:
tions. Mol Cell 34(6):696–709. https://doi. new insights into domains required for
org/10.1016/j.molcel.2009.06.003 miRNA-mediated gene silencing. RNA 15
8 Camille Virciglio et al.
50. Seila AC, Calabrese JM, Levine SS, Yeo GW, Cell Biol 85(4):484–496. https://doi.org/10.
Rahl PB, Flynn RA, Young RA, Sharp PA 1139/O07-061
(2008) Divergent transcription from active 58. Aalto AP, Pasquinelli AE (2012) Small
promoters. Science 322(5909):1849–1851. non-coding RNAs mount a silent revolution
https://doi.org/10.1126/science.1162253 in gene expression. Curr Opin Cell Biol 24
51. Flynn RA, Almada AE, Zamudio JR, Sharp PA (3):333–340. https://doi.org/10.1016/j.
(2011) Antisense RNA polymerase II divergent ceb.2012.03.006
transcripts are P-TEFb dependent and sub- 59. De Santa F, Barozzi I, Mietton F, Ghisletti S,
strates for the RNA exosome. Proc Natl Acad Polletti S, Tusi BK, Muller H, Ragoussis J, Wei
Sci U S A 108(26):10460–10465. https://doi. C-L, Natoli G (2010) A large fraction of extra-
org/10.1073/pnas.1106630108 genic RNA pol II transcription sites overlap
52. Neil H, Malabat C, d’Aubenton-Carafa Y, enhancers. PLoS Biol 8:e1000384. https://
Xu Z, Steinmetz LM, Jacquier A (2009) Wide- doi.org/10.1371/journal.pbio.1000384
spread bidirectional promoters are the major 60. Kim T-K, Hemberg M, Gray JM, Costa AM,
source of cryptic transcripts in yeast. Nature Bear DM, Wu J, Harmin DA, Laptewicz M,
457(7232):1038–1042. https://doi.org/10. Barbara-Haley K, Kuersten S, Markenscoff-
1038/nature07747 Papadimitriou E, Kuhl D, Bito H, Worley PF,
53. van Dijk EL, Chen CL, d’Aubenton-Carafa Y, Kreiman G, Greenberg ME (2010) Widespread
Gourvennec S, Kwapisz M, Roche V, transcription at neuronal activity-regulated
Bertrand C, Silvain M, Legoix-Ne P, enhancers. Nature 465:182–187. https://doi.
Loeillet S, Nicolas A, Thermes C, Morillon A org/10.1038/nature09033
(2011) XUTs are a class of Xrn1-sensitive anti- 61. Kaikkonen MU, Spann NJ, Heinz S, Roma-
sense regulatory non-coding RNA in yeast. noski CE, Allison KA, Stender JD, Chun HB,
Nature 475(7354):114–117. https://doi. Tough DF, Prinjha RK, Benner C, Glass CK
org/10.1038/nature10118 (2013) Remodeling of the enhancer landscape
54. Xu Z, Wei W, Gagneur J, Perocchi F, Clauder- during macrophage activation is coupled to
Munster S, Camblong J, Guffanti E, Stutz F, enhancer transcription. Mol Cell 51:310–325.
Huber W, Steinmetz LM (2009) Bidirectional https://doi.org/10.1016/j.molcel.2013.07.
promoters generate pervasive transcription in 010
yeast. Nature 457(7232):1033–1037. https:// 62. Cinghu S, Yang P, Kosak JP, Conway AE,
doi.org/10.1038/nature07728 Kumar D, Oldfield AJ, Adelman K, Jothi R
55. Mercer TR, Dinger ME, Mattick JS (2009) (2017) Intragenic enhancers attenuate host
Long non-coding RNAs: insights into func- gene expression. Mol Cell 68:104–117.e6.
tions. Nat Rev Genet 10(3):155–159. https://doi.org/10.1016/j.molcel.2017.09.
https://doi.org/10.1038/nrg2521 010
56. Ponting CP, Oliver PL, Reik W (2009) Evolu- 63. Alvarez-Dominguez JR, Knoll M, Gromatzky
tion and functions of long noncoding RNAs. AA, Lodish HF (2017) The super-enhancer-
Cell 136(4):629–641. https://doi.org/10. derived alncRNA-EC7/Bloodlinc potentiates
1016/j.cell.2009.02.006 red blood cell development in trans. Cell Rep
57. Yazgan O, Krebs JE (2007) Noncoding but 19:2503–2514. https://doi.org/10.1016/j.
nonexpendable: transcriptional regulation by celrep.2017.05.082
large noncoding RNA in eukaryotes. Biochem
Chapter 2
RNA Precipitation
Valérie Bourguignon-Igel, Yoann Abel, and Mathieu Rederstorff
Abstract
Precipitation is a critical step to recover RNA of high purity. This chapter describes the principles of
alcoholic precipitation as well as a standard, basic protocol with key advices to observe, but numerous
variations on the theme are discussed. Indeed, several important parameters, such as the choice of salt,
alcohol, or carrier, have to be considered to improve the efficiency of precipitation and the yield of RNA
recovery.
1 Introduction
Mathieu Rederstorff (ed.), Small Non-Coding RNAs: Methods and Protocols, Methods in Molecular Biology, vol. 2300,
https://doi.org/10.1007/978-1-0716-1386-3_2, © Springer Science+Business Media, LLC, part of Springer Nature 2021
11
12 Valérie Bourguignon-Igel et al.
2 Materials
1. 100% ethanol.
2. 70% ethanol.
3. 100% isopropanol.
4. 3 M sodium acetate, pH 5.2.
5. 5 M ammonium acetate.
6. 8 M lithium chloride.
7. 2 M sodium chloride.
8. Yeast tRNA (10–20 μg/ml).
9. Salmon sperm DNA (10–20 μg/ml).
10. Glycogen (50–150 μg/ml).
11. GlycoBlue™ Co-precipitant (50–150 μg/ml).
12. Linear polyacrylamide (10–20 μg/ml).
13. 1 M MgCl2.
14. RNase-free, DEPC-treated water.
15. 1 TE buffer, pH 8.0: 10 mM Tris–HCl, pH 8.0,
1 mM EDTA.
3 Methods
3.1 Ethanol 1. Adjust sample volume to a minimum of 100 μl (see Note 7).
Precipitation 2. Add sodium acetate to the sample to a final concentration of
0.3 M (about 1/10 of volume) (see Notes 1, 3 and 8).
3. Add 2.5 to 3 volumes of ice-cold 100% ethanol (see Note 2).
4. Mix thoroughly by inverting the tube or pipetting up and
down (see Note 9).
5. Incubate on ice for 15 min to 1 h (see Note 4).
6. Centrifuge at 12,000 g for 30 min at 4 C (see Note 5).
7. Carefully discard the supernatant without disturbing the pellet.
8. Wash the RNA pellet with 0.5 ml of 70% ethanol and mix
gently.
RNA Precipitation 13
4 Notes
References
1. Sambrook J, Fritsch EF, Maniatis T (1989) 6. Tracy S (1981) Improved rapid methodology
Molecular cloning, a laboratory manual, 2nd for the isolation oh nucleic acids from agarose
edn. Cold Spring Harbor Laboratory Press, gels. Prep Biochem 11:251–268
Cold Spring Harbor, NY, pp E.10–E.15 7. Gaillard C, Strauss F (1990) Ethanol precipita-
2. Zumbo P (2012) Ethanol precipitation. tion of DNA with linear polyacrylamide as car-
Department of Physiology & Biophysics, rier. Nucleic Acids Res 18:378
Weill Cornell Medical College 8. Baugh LR et al (2001) Quantitative analysis of
3. Barlow J et al (2001) A simple method for the mRNA amplification by in vitro transcription.
quantitative isolation of Undegraded high Nucleic Acids Res 29:E29
molecular weight ribonucleic acid. Biochem 9. Aruffo A, Seed B (1987) Molecular cloning of
Biophys Res Commun 13:61–66 a CD28 cDNA by a high-efficiency COS cell
4. Michelson AM, Orkin SH (1982) Characteri- expression system. Proc Natl Acad Sci
zation of the Homopolymer tailing reaction 84:8573–8577
catalyzed by terminal deoxynucleotidyl trans- 10. Strauss F, Varshavsky A (1984) A protein binds
ferase. J Biol Chem 257:14773–14782 to a satellite DNA repeat at three specific sites
5. Wang QT et al (2002) Yeast tRNA as carrier in that would be brought into mutual proximity
the isolation of microscale RNA for global by DNA folding in the nucleosome. Cell
amplification and expression profiling. Bio- 37:889–901
Techniques 33:788–796 11. Zeugin J, Hartley JL (1985) Ethanol precipita-
tion of DNA. Focus 7:1–2
Chapter 3
Abstract
Recent advances in high-throughput sequencing have shed new light on the diversity of small noncoding
RNA (sncRNA) classes and their crucial roles in gene regulation and disease. One key step in sncRNA
profiling consists in their quantification and assessment of their degradation extent. In this chapter, we will
describe different gold standard methods used to achieve both purposes before using the sncRNAs in
downstream applications.
1 Introduction
Mathieu Rederstorff (ed.), Small Non-Coding RNAs: Methods and Protocols, Methods in Molecular Biology, vol. 2300,
https://doi.org/10.1007/978-1-0716-1386-3_3, © Springer Science+Business Media, LLC, part of Springer Nature 2021
17
18 Virginie Marchand et al.
2 Materials
2.1.2 Using 1. Any kind of fluorometer able to quantify RNA, DNA, and
a Fluorometer proteins with high sensitivity, e.g., Qubit 3.0 Fluorometer
(Life technologies) which is the one we use.
2. Thin-walled polypropylene tubes of 500 μl, compatible with
the fluorometer (e.g., Qubit Assay Tube or Axygen PCR-05-C
tubes, VWR)
3. RNA assay kit: Qubit RNA Assay Kit (5–100 ng), Qubit RNA
BR Assay Kit (20–1000 ng), Qubit microRNA Assay Kit
(1–500 ng).
4. Optional: Qubit dsDNA HS Assay Kit (0.2–100 ng) and Qubit
Protein Assay Kit (0.25–5 μg).
3 Methods
3.1 RNA Carry out all procedures at room temperature unless otherwise
Quantification specified.
3.1.1 Using 1. Select the “Nucleic Acids” tab from the home screen of the
a Spectrophotometer NanoDrop One spectrophotometer.
2. Pipette and load 1 μl of a blank solution (e.g., RNase-free water
or TE buffer) onto the lower pedestal and lower the arm.
3. If “Auto-blank” is On, the blank measurement starts automat-
ically, otherwise select “Blank” and wait for the measurement
to complete.
4. Lift the arm and clean both pedestals with a clean wipe.
5. Pipette and load 1 μl of the sample solution onto the pedestal,
lower the arm (see Note 4).
6. If “Auto-Measure” is On, the sample measurement starts auto-
matically, otherwise select “Measure” and wait for the measure-
ment to complete. The spectrum and reported values are
displayed.
7. When you are done with sample measurements, select “End
Experiment” and export data on a USB stick.
8. Lift the arm and clean both pedestals with a new wipe.
9. Analyze the data obtained for your different RNA samples. The
concentration of your RNA sample based on the absorbance at
260 nm is given in “ng/μl” by default setting. The “A260/
A280” ratio is provided. This ratio is used to roughly assess the
purity of your RNA preparation. A ratio of 2 is generally
considered as “pure” RNA. The “A260/A230” ratio is
provided as well. This ratio is used to assess RNA purity. For
“pure” RNAs, it should be in the range of 1.8–2.2 (see Note 5).
In addition, if you use the NanoDrop One, its technology
will enable to identify most contaminants (phenol, proteins,
etc.).
Quantity and Quality Control of Small RNAs 21
Table 1
Overview of the technical specifications for the Agilent RNA 6000 Nano, RNA 6000 Pico, and Small
RNA kits
3.1.2 Using 1. Equilibrate all solutions of the appropriate kit at room temper-
a Fluorometer ature for at least 30 min before starting the experiments. The
kit provides the concentrated assay reagent, dilution buffer,
and pre-diluted standards (see Note 6).
2. Prepare the dye working solution by diluting the concentrated
assay reagent 200 times in dilution buffer. Prepare 200 μl of
working solution for each sample and the two standards.
3. Prepare the two standards annotated “C” and “D” by mixing
10 μl of standard with 190 μl of working solution.
4. Add working solution up to 200 μl to 1–20 μl of RNA sample.
5. Vortex the tubes for 2 s and incubate them for 2 min at room
temperature.
6. On the home screen of the Qubit 3.0 Fluorometer, select the
quantification assay “RNA” for which you want to perform a
new calibration.
7. Select “Read standards” to perform a calibration.
8. When indicated, insert the standard #1 tube and select “Read
standard.” Standard #1 and #2 correspond to standards “C”
and “D,” respectively.
9. Once the calibration is done, select “Run samples” to make the
measurements.
10. Indicate with the + and buttons on the wheel, the sample
volume added to the assay tube and select the units for the
output sample concentration.
11. Insert a sample tube into the sample chamber, close the lid and
then select “Read tube.”
12. Read the results, remove the current sample and insert a
new one.
13. To address if your RNA sample preparation is contaminated by
DNA or proteins, repeat the experiment with the DNA and/or
Protein kits (see Note 7).
3.2.2 Capillary 1. Prepare the ladder provided in the kit: Spin down the tube and
Electrophoresis transfer 10 μl of it to a RNase-free tube. Heat for 2 min at
70 C. Cool down on ice and add 90 μl of RNase-free water.
Prepare 5 μl aliquots using the Safe-Lock PCR Tubes provided
in the kit and store them at 70 C. Before use, thaw one tube
and keep it on ice (Fig. 1a) (see Note 8).
2. Equilibrate all solutions of the kit at room temperature for at
least 30 min before starting the experiments (see Note 6).
3. Place 550 μl (Agilent RNA 6000 Nano or Pico kit) or 650 μl
(Agilent Small RNA kit) of the gel matrix (red cap vial) into a
dedicated spin filter. Spin at room temperature for 10 min at
1500 g (Agilent RNA 6000 Nano or Pico kit) or for 15 min
at 10,000 g (Agilent Small RNA kit) (Table 1) (Fig. 1b).
4. Prepare 65 μl (Agilent RNA 6000 Nano or Pico kit) or 40 μl
(Agilent Small RNA kit) aliquots of the gel and store them at
4 C for a maximum of 1 month.
5. To avoid contamination of your RNA samples by RNases, clean
the electrodes before and after each experiment by filling one of
the wells of the electrode cleaner with 350 μl of fresh RNase-
free water (see Note 9).
6. Place the electrode cleaner in the Agilent 2100 bioanalyzer and
wait for 5 min before removing it.
7. Wait for 30 min to allow evaporation of the water from the
electrodes (see Note 10).
8. Prepare the gel–dye mix by adding 1 μl (Agilent RNA 6000
Nano or Pico kit) or 2 μl (Agilent Small RNA kit) of RNA dye
concentrate (blue cap vial) to a gel aliquot. Mix by pipetting up
and down and centrifuge for 10 min at 13,000 g at room
temperature (Fig. 1c).
9. During centrifugation, prepare your samples as follows: Dilute
your RNA samples with RNase-free water to be within the
optimal range concentration of the assay (Table 1).
10. Heat the diluted RNA samples for 2 min at 70 C to prevent
formation of secondary structures and cool them down on ice
(Fig. 1d).
11. Add 1 μl of your diluted RNA samples to 11 (or 12) tubes of
1.5 ml containing 5 μl of RNA marker (green cap vial) (see
Notes 11 and 12) (Table 1). Mix by pipetting up and down
(Fig. 1d).
12. Mix 1 μl of the ladder with 5 μl of RNA marker (green cap vial)
in a 1.5 ml tube (see Note 13) (Table 1). Mix by pipetting up
and down (Fig. 1d).
24 Virginie Marchand et al.
a) e)
1-3 G
4-6 G
7-9 G
CS
CS
+ 65 μl gel
aliquot
Centrifuge for
Load 9 μl of Conditioning Solution
10 min at 13,000 g at RT
G
G
1 μl Gel-dye mix ready
dye concentrate G
CS
G
5 μl ladder G
aliquot Mix by pipetting
CS
up and down
6 μl diluted ladder
1 μl ladder
Load 6 μl of Diluted RNA sample
G
CS
+ + +
12 empty
1.5 ml tubes
Fig. 1 Quick guide for RNA Pico Chip preparation and loading. (a) Ladder preparation. (b) Gel preparation. (c)
Gel–dye mix preparation. (d) Samples and ladder preparation. (e) RNA Pico Chip loading
Quantity and Quality Control of Small RNAs 25
13. Prepare the chip priming station before loading the gel–dye
mix. Check that the base plate is adjusted in its default position
(C position) (Fig. 1e).
14. Open a new syringe, slide it into the hole of the lock adapter
and screw it to the priming station. Adjust the plunger to 1 ml
(Fig. 1e).
15. Adjust the syringe clip to the highest top (Agilent RNA 6000
Nano or Pico kit) or to the lowest top (Agilent Small RNA kit)
position (see Table 1).
16. Once you are ready, load 9 μl of the gel–dye mix in the well
marked with a “G” surrounded by a black circle (see Note 14)
(Fig. 1e).
17. Close properly the chip priming station (see Note 15) and press
the plunger of the syringe until it is hold by the clip (Fig. 1e).
18. Wait exactly for 30 s (Agilent RNA 6000 Nano or Pico kit) or
60 s (Agilent Small RNA kit) and then release the clip.
19. Wait for 5 s until the plunger stops its upward move and pull it
slowly back to the 1 ml position.
20. Open the chip priming station and load 9 μl of gel–dye mix in
the other wells marked with a “G.”
21. Load 9 μl of the conditioning solution (not for the Agilent
RNA 6000 Nano kit) in the well marked “CS” (Fig. 1e).
22. Load 6 μl of the diluted ladder in the well marked with a ladder
(Fig. 1e).
23. Load 6 μl of the diluted RNA samples in the wells marked 1–11
(for Agilent RNA 6000 Pico and Small RNA kit) or 1–12 (for
Agilent RNA 6000 Nano kit) (Fig. 1e).
24. Inspect the chip and make sure that no liquid is present on the
edges of the wells. If any, pipet it away (see Note 14).
25. Insert the chip in the Agilent 2100 Bioanalyzer.
26. Carefully close the lid. The electrodes of the cartridge will enter
into the wells of the chip (see Note 15).
27. The 2100 expert software screen shows that you have inserted
a chip by displaying a chip icon on the top left corner of the
screen.
28. Select the appropriate assay you want to perform (e.g., eukary-
otic total RNA Pico series II).
29. Press “Start” to begin the chip run (see Note 16).
30. After the run, immediately remove the chip and clean the
electrodes (see Note 10).
31. Analyze the results of the chip (Fig. 2).
26 Virginie Marchand et al.
a A
RN tal R
NA
total to
t n
ec uma
ins h
Total RNA extracted from human PBMC cells (RIN=8.7)
[FU]
200
100
0
(nt)
25 500 4000 [nt] 4000
Total RNA extracted from insect cells (RIN=NA)
[FU] 2000
200 1000
500
200
0
25
25 500 4000 [nt]
RIN NA 8.7
b
Total RNA extracted from human PBMC cells (RIN=9.3)
[FU]
18S rRNA 28S rRNA
re
NA xtu
200 lR mi NA
ota NA m iR
100
sRNAs nt tt R
ed
ma a s rifi
hu ye pu
0
25 500 4000 [nt]
yeast tRNA mixture (RIN=2.6)
[FU]
1000
(nt)
500
4000
0
25 500 4000 [nt] 2000
Synthetic miRNA (RIN=2.6)
1000
[FU]
500
200
25
0
RIN 9.3 2.6 2.6
25 500 4000 [nt]
50 miRNA tRNA
re
NA xtu
lR mi NA
ota NA m iR
0 nt t tR ed
ma as rifi
hu ye pu
4 20 60 100 150 [nt]
(nt)
0
4 20 60 100 150 [nt] 150
miRNA tRNA
Fig. 2 Examples of RNA profiles obtained using the Agilent 2100 Bioanalyzer. (a) High-quality insect or human
total RNA obtained after Trizol extraction analyzed on an RNA Pico Chip. The human total RNA trace profile is
Quantity and Quality Control of Small RNAs 27
4 Notes
Fig. 2 (continued) typical of a high-quality RNA since the 28S and 18S rRNA peaks are present and dominant.
A RIN (RNA Integrity Number) of 8.7 was attributed to the RNA sample, which is indicative of good quality. Note
the presence of abundant small RNAs including 5.8S and 5S rRNAs, tRNAs, and other noncoding RNAs ranging
from 25 to 200 nts. The insect total RNA trace profile is also typical of a high-quality RNA sample, even though
it looked like degraded and no RIN could be attributed since the 28S rRNA peak is absent. Indeed, upon heat
denaturation, the insect 28S rRNA is cleaved leading to fragments migrating with the 18S rRNA. (b) RNA trace
profiles obtained on a Pico RNA chip for a yeast total tRNA preparation and a synthetic miRNAs sample (21 nt)
were compared to a human total RNA preparation. As expected, yeast tRNA mixture and synthetic miRNA both
migrate as the small RNAs of the human total RNA preparation. (c) RNA trace profiles obtained on a Small RNA
chip for a yeast total tRNA preparation and a synthetic miRNAs sample (21 nt) were compared to a human total
RNA preparation. The human total RNA preparation leads to three major peaks, one between 50 and 80 nts,
corresponding mainly to tRNAs, one around 90 nts corresponding to snoRNAs, and one around 140 nts
corresponding to the 5.8S rRNA. 5S rRNA corresponds to a small pic at 120 nts. Though miRNAs are detected
in this sample, they represent too small a portion of total RNAs and are therefore not visible on the RNA trace
profile
28 Virginie Marchand et al.
References
1. Rave N, Crkvenjakov R, Boedtker H (1979) Granzow M, Ragg T (2006) The RIN: an RNA
Identification of procollagen mRNAs trans- integrity number for assigning integrity values to
ferred to diazobenzyloxymethyl paper from RNA measurements. BMC Mol Biol 7:3
formaldehyde agarose gels. Nucleic Acids Res 5. Daniell H, Chebolu S, Kumar S, Singleton M,
6:3559–3567 Falconer R (2005) Chloroplast-derived vaccine
2. Aranda PS, LaJoie DM, Jorcyk CL (2012) antigens and other therapeutic proteins. Vaccine
Bleach gel: a simple agarose gel for analyzing 23:1779–1783
RNA quality. Electrophoresis 33:366–369 6. Winnebeck EC, Millar CD, Warman GR (2010)
3. Becker C, Hammerle-Fickinger A, Riedmaier I, Why does insect RNA look degraded? J Insect
Pfaffl MW (2010) mRNA and microRNA qual- Sci 10:159
ity control for RT-qPCR analysis. Methods 7. Wilfinger WW, Mackey K, Chomczynski P
50:237–243 (1997) Effect of pH and ionic strength on the
4. Schroeder A, Mueller O, Stocker S, Salowsky R, spectrophotometric assessment of nucleic acid
Leiber M, Gassmann M, Lightfoot S, Menzel W, purity. BioTechniques 22(474–476):478–481
Chapter 4
Abstract
The assessment of non-coding RNAs (ncRNAs) functions highly relies on loss of function studies.
However, due to their exclusive or partial nuclear localization, many small and long ncRNAs are not
efficiently silenced by RNA interference. Antisense LNA GapmeRs constitute a good alternative to
RNAi. They allow an effective knockdown of ncRNAs with sizes greater than 80 nucleotides, regardless
of their cellular localization. This chapter focuses on the silencing of two different nuclear ncRNAs (ANRIL
and SATIII RNAs) in mammalian cells using antisense LNA GapmeRs with two different transfection
methods: calcium phosphate-mediated transfection and LipofectamineTM 2000.
Key words lncRNA silencing, Antisense LNA GapmeRs, Calcium phosphate transfection, Lipofecta-
mineTM 2000, ANRIL, SATIII
1 Introduction
Mathieu Rederstorff (ed.), Small Non-Coding RNAs: Methods and Protocols, Methods in Molecular Biology, vol. 2300,
https://doi.org/10.1007/978-1-0716-1386-3_4, © Springer Science+Business Media, LLC, part of Springer Nature 2021
31
32 Charbel Alfeghaly et al.
Transcription
ncRNA
LNA DNA LNA
Antisense LNA GapmeR
Nucleus
RNaseH
RNase
RNase H cleavage
Degraded ncRNA
A. B. C.
100 LNA CTL 100 LNA CTL 100 LNA CTL
LNA SATIII 6h LNA ANRIL LNA ANRIL
60 60 60
40 40 40
19 25
19.9
20 20 20
4.8
0 0 0
SATIII ANRIL ANRIL
Fig. 2 Silencing of SATIII and ANRIL lncRNAs using specific antisense LNA GapmeRs. (a) Calcium phosphate-
mediated transfection of HeLa S3 cells is used to deliver either LNA GapmeRs specifically targeting SATIII RNA
(LNA SATIII) or LNA oligonucleotides against the GFP gene (LNA CTL) as a negative control. The efficiency of
SATIII knockdown is monitored by RT-qPCR. Transfection of SATIII LNA dramatically reduces the expression
level of SATIII RNAs and this effect is greater 6 h post-transfection compared to 24 h. Values are calculated
from three independent experiments and normalized against GAPDH mRNA level. The level of the SATIII RNA is
expressed relatively to the level of the control (100%). (b) Calcium phosphate-mediated transfection of
HEK293 cells is used to deliver either LNA GapmeRs specifically targeting ANRIL (LNA ANRIL) or a scrambled
sequence (LNA CTL) as a negative control. Efficiency of ANRIL knockdown is monitored by RT-qPCR.
Transfection of LNA ANRIL reduces ANRIL expression up to 80% 48 h post-transfection. Values are calculated
from three independent experiments and normalized against GAPDH mRNA levels. The level of ANRIL is
expressed relatively to the level of the control (100%). (c) Lipofectamine 2000 is used to transfect HEK293
cells with either LNA GapmeRs specifically targeting ANRIL (LNA ANRIL) or a scrambled sequence (LNA CTL) as
a negative control. Efficiency of ANRIL knockdown is monitored by RT-qPCR, which shows an efficient
reduction in ANRIL’s expression up to 75%, similarly to the calcium phosphate method. Values are calculated
from one experiment and normalized against GAPDH mRNA levels. The level of ANRIL is expressed relatively to
the level of the control (100%). Means SEM are shown
2 Materials
2.1 Mammalian Cell 1. HeLa S3 cells and HEK293 cells (ATCC) (see Note 1).
Culture 2. DMEM (Dulbecco’s Modified Eagle Medium) cell culture
medium, supplemented with 10% of fetal calf serum, 2 mM
L-glutamine, 100 U/ml of penicillin, and 100 μg/ml of
streptomycin.
3. Six-well plates (for 100-mm dishes, reagent quantities are mul-
tiplied by 6).
Non-Coding RNA Silencing 35
2.2 Antisense LNA Chemically modified antisense LNA GapmeRs are produced by
GapmeRs Exiqon-Qiagen, resuspended in nuclease-free H2O to a concentra-
(Exiqon-Qiagen) tion between 50 and 100 μM (see Note 2) and stored as aliquots at
20 C to avoid repeated freeze and thaw cycles.
3 Methods
4 Notes
Acknowledgments
This work was supported partly by the french PIA project “Lorraine
Université d’Excellence” (ANR-15IDEX-04-LUE) and the RHU
program FIGHT-HF (ANR-15-RHU-004). The CNRS and UL
are also thanked for fundings.
References
1. Liang XH, Vickers TA, Guo S, Crooke ST analog in therapeutics and biotechnology. Oli-
(2011) Efficient and specific knockdown of gonucleotides 14:130–146
small non-coding RNAs in mammalian cells 8. Biamonti G, Vourc’h C (2010) Nuclear stress
and in mice. Nucleic Acids Res 39(3):e13 bodies. Cold Spring Harbor Perspectives in
2. Ploner A, Ploner C, Lukasser M, Biology
Niederegger H, Huttenhofer A (2009) Meth- 9. Rosic S, Köhler F, Erhardt S (2014) Repetitive
odological obstacles in knocking down small centromeric satellite RNA is essential for kinet-
noncoding RNAs. RNA 15:1797–1804 ochore formation and cell division. J Cell Biol
3. Singh SK, Koshkin AA, Wengel J, Nielsen P 207:335–349
(1998) LNA (locked nucleic acids): synthesis 10. Ninomiya K, Adachi S, Natsume T, Iwakiri J,
and high-affinity nucleic acid recognition. Terai G, Asai K, Hirose T (2019) LncRNA-
Chem Commun 1998:455–456 dependent nuclear stress bodies promote
4. Judge AD, Bola G, Lee AC, MacLachlan I intron retention through SR protein phosphor-
(2006) Design of noninflammatory synthetic ylation. EMBO J 29:e102729. https://doi.
siRNA mediating potent gene silencing org/10.15252/embj.2019102729
in vivo. Mol Ther 13:494–505 11. Kotake Y, Nakagawa T, Kitagawa K, Suzuki S,
5. Graham FL, van der Eb AJ (1973) A new tech- Liu N, Kitagawa M, Xiong Y (2011) Long
nique for the assay of infectivity of human ade- non-coding RNA ANRIL is required for the
novirus 5 DNA. Virology 52:456–467 PRC2 recruitment to and silencing of
6. Felgner PL, Gadek TR, Holm M, Roman R, p15INK4B tumor suppressor gene. Oncogene
Chan HW, Wenz M, Northrop JP, Ringold 30:1956–1962
GM, Danielsen M (1987) Lipofection: a highly 12. Yap KL, Li S, Muñoz-Cabello AM, Raguz S,
efficient, lipid-mediated DNA-transfection Zeng L, Mujtaba S, Gil J, Walsh MJ, Zhou
procedure. Proc Natl Acad Sci 84:7413–7417 M-M (2010) Molecular interplay of the non-
7. Jepsen JS, Sorensen MD, Wengel J (2004) coding RNA ANRIL and methylated histone
Locked nucleic acid: a potent nucleic acid H3 lysine 27 by Polycomb CBX7 in transcrip-
tional silencing of INK4a. Mol Cell
38:662–674
Part II
To tell this part of the story of Dr. Mateer’s life satisfactorily, I must
begin with the first general missionary conference, held at Shanghai
in May, 1877. For two years previous he had served on a committee
to prepare the way for the meeting, and in this capacity he had
rendered much valuable assistance. At that conference he read a
paper in which he elaborately discussed the subject of “The Relation
of Protestant Missions to Education.” The meeting was regarded as
successful, and a second was called, to assemble at Shanghai, in
May, 1890. It was at this conference that the movement for a revision
of the Bible in Chinese took actual measures toward realization.
For the sake of any readers not well informed as to the Chinese
language, a few preliminary statements concerning it may be
desirable here. In a very broad and general sense it may be said that
as to elements, one tongue prevails throughout China proper; but
that there is also much important variation in this general tongue.
First of all, it needs lo be noted that the language takes on two
principal forms,—the classic, or Wen-li, and the spoken, or
Mandarin. The classic has come down through the centuries from
the times of Confucius and Mencius, and remains comparatively the
same as it is found in the writings of those sages. This is accepted
as the model for all writing; and for that reason Chinese students
have been required to spend the greater part of their time in
memorizing those ancient books, so that they might not only absorb
their teaching, but also especially that they might be able to
reproduce their style. The classic Chinese is stilted and so
condensed that in comparison with it a telegram would seem diffuse;
and though many of the characters are the same as those used in
writing the spoken language, yet the meaning and often the sound of
characters is so different that an illiterate person would not
understand it on hearing it read. The spoken language, on the other
hand, may be compared with English as to its use. Good English is
very much the same throughout the countries where it is the
vernacular, and though it takes on local dialects, it remains
everywhere intelligible. So, broadly speaking, is it also as to the
spoken Chinese in a large part of the empire. From the Yangtse up
into Manchuria, though the pronunciations differ very much, the
colloquial if put into writing is understood. In other words, with
differences of dialect and pronunciation it is the speech of perhaps
three hundred millions of people. The regions excepted lie along the
coast from Shanghai down, and inland south of the Yangtse, where
the distinct tongues are numerous and are largely unintelligible
except in their own localities.
It has been the rule in China that a mandarin must not be a native
of the province where he holds office; and, of course, it is essential
that he should be acquainted with the speech which constitutes the
lingua franca. Perhaps for this reason it is called Mandarin. But down
to the time when missionary publications rendered it common in
print, it was not employed in that mode. All books, business or
government documents, the one newspaper of the country, which
was the court gazette, and all letters were in the higher or, as it is
called, the Wen-li form, the only exception being some novels, and
even these were streaked with Wen-li. This, however, ran through
gradations,—from the highest, which is so condensed and so bristles
with erudite allusions that only a trained scholar can understand it,
down to a modification which is so easy that with a slight alteration of
particles it is almost the same as the Mandarin.
During the long period of the nineteenth century preceding the
meeting of the second general missionary conference, a number of
translations of the Scriptures, some of them of the whole, and some
of parts, had been made, and had come more or less into use. The
men who did this pioneer work deserve to be held in perpetual
esteem, especially in view of the difficulties under which they
labored. Among the missionaries who sat in that conference there
was no disposition to withhold this honor, or to disparage the value of
these early translations; but there was so widely prevalent among
them and their associates at that time on the field a conviction that
no existing version was satisfactory, that they recognized it as a duty
to take up the subject, and to initiate steps looking to the production
of a better. An informal consultation as to this was held by a few
men, a couple of days before the conference assembled; but
inasmuch as Dr. Mateer had not been invited, he did not attend.
Another consultation was held the following day, and because of his
great interest in the subject of a Bible revision, he attended without
an invitation. The views expressed clearly indicated that there was a
general agreement that a revision was desirable, but it also was
made very plain that beyond this there was a wide divergence of
opinion. We will allow one of his letters to a representative of the
American Bible Society, under date of May 26, 1890, to tell the next
step in this great undertaking:
The differences are not great, and where they exist, the
versions will serve Chinese students as a sort of commentary.
There are a multitude of questions in Biblical interpretation
which no translation can settle once for all. Moreover, ninety-
nine out of a hundred of those who use the Mandarin will
never look at any other translation. Two versions in perfect
accord seem like a fine product, but it is difficult of realization.
An attempt at reconciling the present versions would develop
many difficulties. A Mandarin sentence especially is not easy
to tamper with. The change of a single word would often
dislocate a long sentence, and necessitate retranslation and
adjustment to the context.